AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
08 May 2014 12:31 PM
RNS
ASTRAZENECA INITIATES PHASE III STUDY FOR MEDI4736
08 May 2014 11:32 AM
BZW
Form 8.3 - Astrazeneca Plc
08 May 2014 11:02 AM
RNS
Rule 2.10 Announcement
07 May 2014 05:30 PM
RNS
Holding(s) in Company
07 May 2014 04:56 PM
BZW
Form 8.3 - Astrazeneca Plc
07 May 2014 03:27 PM
BZW
Form 8.3 - AstraZeneca Plc
07 May 2014 01:41 PM
BZW
Form 8.3 - AstraZeneca PLC
07 May 2014 01:39 PM
BZW
Form 8.3 - Astrazenica Plc
07 May 2014 11:18 AM
BZW
Form 8.3 - Astrazeneca Plc
07 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
06 May 2014 04:02 PM
BZW
Form 8.3 - ASTRAZENECA PLC
06 May 2014 03:30 PM
RNS
Changes to membership of Board Committees
06 May 2014 03:12 PM
BZW
Form 8.3 - AstraZeneca Plc
06 May 2014 01:12 PM
BZW
Form 8.3 - AstraZeneca PLC
06 May 2014 01:10 PM
BZW
Form 8.3 - AstraZeneca PLC
06 May 2014 12:31 PM
BZW
Form 8.3 - Astrazeneca Plc
06 May 2014 11:30 AM
RNS
Rule 2.10 Announcement
06 May 2014 11:00 AM
RNS
ASTRAZENECA ISSUES UPDATE ON STRATEGY
06 May 2014 07:01 AM
RNS
US FDA APPROVES EPANOVA
06 May 2014 07:00 AM
BZW
Form 8.3 - Astrazeneca - Amendment
06 May 2014 07:00 AM
BZW
Form 8.3 - AstraZeneca Plc
02 May 2014 04:07 PM
BZW
Form 8.3 - AstraZeneca
02 May 2014 03:06 PM
BZW
Form 8.3 - AstraZeneca Plc
02 May 2014 02:24 PM
BZW
Form 8.3 - Astrazeneca Plc
02 May 2014 01:41 PM
BZW
Form 8.3 - AstraZeneca PLC
02 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
02 May 2014 10:50 AM
RNS
ASTRAZENECA BOARD REJECTS PFIZER PROPOSAL
02 May 2014 08:09 AM
RNS
STATEMENT REGARDING PFIZER ANNOUNCEMENT
01 May 2014 04:47 PM
BZW
Form 8.3- ASTRAZENECA PLC
01 May 2014 03:28 PM
BZW
Form 8.3 - AstraZeneca Plc
01 May 2014 01:37 PM
BZW
Form 8.3 - AstraZeneca plc
01 May 2014 01:15 PM
BZW
Form 8.3 - AstraZeneca PLC
01 May 2014 11:00 AM
RNS
Rule 2.10 Announcement
01 May 2014 11:00 AM
RNS
Total Voting Rights
30 Apr 2014 03:29 PM
BZW
Form 8.3 - AstraZeneca Plc
30 Apr 2014 02:24 PM
BZW
Form 8.3 - Astrazeneca Plc
30 Apr 2014 02:09 PM
BZW
Form 8.3 - AstraZeneca PLC
30 Apr 2014 11:00 AM
RNS
Rule 2.10 Announcement
29 Apr 2014 04:30 PM
RNS
Rule 2.10 Announcement
29 Apr 2014 03:32 PM
BZW
Form 8.3 - AstraZeneca Plc
29 Apr 2014 02:46 PM
BZW
Form 8.3 - AstraZeneca PLC
29 Apr 2014 01:38 PM
BZW
Form 8.3 - Astrazeneca Plc
29 Apr 2014 10:52 AM
BZW
Form 8.3 - AstraZeneca PLC
29 Apr 2014 08:36 AM
BZW
Form 8.3 - AstraZeneca PLC
28 Apr 2014 11:34 AM
BZW
Form 8.3 - Astrazeneca Plc - Replacement
28 Apr 2014 10:41 AM
BZW
Form 8.3 - Astrazeneca Plc
28 Apr 2014 10:35 AM
RNS
Statement Regarding Pfizer Announcement
24 Apr 2014 05:20 PM
RNS
Result of AGM
24 Apr 2014 07:08 AM
RNS
1st Quarter Results - Part 2
24 Apr 2014 07:08 AM
RNS
1st Quarter Results

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings